Current Positions
•Chief Physician, Professor, Doctoral Supervisor
•Director of Medical Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine
•Director, MDT Expert Committee, Renji Hospital
•MDT Team Leader for Cancers of Unknown Primary Origin & Multiple Primary Malignancies, Renji Hospital
•Director, Shanghai Jiao Tong University Pancreatic Cancer Diagnosis and Treatment Center
•Director, Oncology Clinical Drug Trial Base
•Consultant of Jiahui International Cancer Center

Clinical Expertise & Research Focus
•Personalized precision diagnosis and treatment of various complex and difficult tumors
•Translational research on gastrointestinal tumors, especially pancreatic cancer precision diagnosis and treatment
•Oncology multidisciplinary team (MDT) diagnosis and treatment
•Individualized targeted therapy and immunotherapy guided by clinical tumor genomics
•Special expertise in precision treatment models for cancers of unknown primary and multiple primary tumors

Academic Appointments
•Head, Pancreatic Tumor Group, Chinese Society of Oncology, Chinese Medical Association
•Council Member, Chinese Society of Clinical Oncology (CSCO)
•First Director, CSCO Pancreatic Cancer Expert Committee
•Council Member, China Anti-Cancer Association (CACA), and First Director, CACA Integrated Onco-Nephrology Committee
•Council Member, Shanghai Medical Association; Director, Oncology Internal Medicine Branch
•Vice Chairman, Shanghai Anti-Cancer Association; Director, Difficult Tumor Professional Committee
•President, Yangtze River Delta Cancer Specialty Alliance
•Leading Talent of Shanghai; Outstanding Academic Leader of Shanghai

Research Achievements
•Visiting researcher at UCLA and MD Anderson Cancer Center (2001–2004)
•Led development of China’s first Chinese Expert Consensus on Comprehensive Diagnosis and Treatment of Pancreatic Cancer
•Led development of the first CSCO Pancreatic Cancer Diagnosis and Treatment Guidelines
•Led development of the first CACA Technical Guidelines for the Protection of Cancer-Related Kidney Diseases
•Principal Investigator of 7 National Natural Science Foundation of China (NSFC) projects, including major research plans
•Principal Investigator of 2 major new drug creation projects and over 10 other fund projects
•Founded China’s first “Pancreatic Cancer Internet+ Consultation Platform” and “China Advanced Pancreatic Cancer Registry Platform”
•Published over 100 SCI-indexed papers with over 1,000 citations
•Associate Editor, Journal of Pancreatology; Editorial Board Member, Cancer Research, Journal of Hematology & Oncology (JHO), etc.